Robert Spitale, associate professor of pharmaceutical sciences, is one of five winners of 2019 Ono Pharma Breakthrough Science Initiative Awards, intended to accelerate high-risk and high-reward science research projects that could lead to discoveries, solutions and potential breakthrough treatments for patients. The award is for three years and provides $900,000 in direct funds for selected […]
New, safer approach using engineered stem cells could reduce need for chemotherapy
Claudia Benavente, an assistant professor of pharmaceutical sciences and developmental & cell biology at UCI, has received a $2.1 million grant from the National Cancer Institute to develop a novel therapeutic treatment for osteosarcoma. Her research aims to explain the role of the chromatin remodeling protein UHRF1 as a potential target in the treatment of […]
UCI-led stem cell study sets stage for human testing
Renowned academic leader will oversee new College of Health Sciences
UCI’s Center for Advanced Design and Manufacturing of Integrated Microfluidics has received a $750,000 grant from the National Science Foundation for ongoing research into developing miniature devices that can perform biochemical analytical functions quickly and inexpensively. These chips have the potential to rapidly detect dangerous toxins in the blood, quickly screen hundreds of potential drugs, […]
“Lab on a chip” technology can be used to create individualized treatments for cancer
Renowned leader from UC San Diego will help drive research, delivery innovations at UCI
Claudia Benavente, assistant professor of pharmaceutical sciences and developmental & cell biology, was awarded a $100,000 grant through the American Association for Cancer Research (AACR). The AACR-Aflac Incorporated Career Development Award for Pediatric Cancer Research is given every year to a project believed to have significant impact in the field of pediatric cancer research. Benavente’s […]
Innovation could advance pharmaceutical, cancer prevention research